Common Contracts
2 similar Master Agreement contracts by Theravance Inc
EX-10.1 2 a14-7412_1ex10d1.htm EX-10.1 MASTER AGREEMENTMaster Agreement • May 5th, 2020 • Delaware
This Master Agreement (the “Agreement”) is entered into effective March 3, 2014 between Theravance, Inc., a Delaware corporation (“Theravance”), Theravance Biopharma, Inc., a Cayman Islands exempted company (“Theravance Biopharma”), and Glaxo Group Limited, a private company limited by shares registered under the laws of England and Wales (“GSK”).
MASTER AGREEMENTMaster Agreement • March 6th, 2014 • Theravance Inc • Pharmaceutical preparations • Delaware
This Master Agreement (the “Agreement”) is entered into effective March 3, 2014 between Theravance, Inc., a Delaware corporation (“Theravance”), Theravance Biopharma, Inc., a Cayman Islands exempted company (“Theravance Biopharma”), and Glaxo Group Limited, a private company limited by shares registered under the laws of England and Wales (“GSK”).
